Nurturing Ingenuity
Collaborating for Growth
Services & Labs
Digital Health
Data Research Center
Hadassah Accelerator
Business Initiatives
Licensing Technologies
About Us
For Researchers
News & Events
Contact
My Briefcase
What’s new at Hadasit
Filter by:
News
Events
Newsletters
Articles
News
April 25, 2023
Israeli universities and hospitals churn out startups as ties with tech industry grow
News
April 24, 2023
Hadasit’s portfolio company NeuroGenesis receives FDA clearance for Phase IIb study
News
April 18, 2023
Gamida Cell receives FDA approval for blood cancer therapy, developed in collaboration with Prof. Amnon Peled, Hadassah
News
March 21, 2023
P-Cure’s Prothon therapy deployed in collaboration with Hadassah Medical Center received FDA clearance
News
December 02, 2022
Hadassah scientists derived male and female cells from same person for the first time in the world
News
October 20, 2022
Exosomm reaches Calcalist and Tnuva’s FoodTech competition final stage
News
August 17, 2022
Hadasit portfolio company Enlivex Therapeutics has received approval for initiation the multicenter Phase I/II Trial of Allocetra
News
March 08, 2022
Promising results of the novel cell therapy against progressive Multiple Sclerosis in its latest clinical trial
News
March 01, 2022
Hadassah Digital Health Accelerator Cohort 4 Graduation
News
December 21, 2021
רוש רוכשת מליניאג’ את זכויות הפיתוח והשיווק של סלקיור
News
December 20, 2021
Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders
News
October 11, 2021
Three Israeli hospitals make Newsweek’s list of top cardiology centers
News
August 29, 2021
Hadassah, Hebrew University and SHL collaboration for developing AI tools in telemedicine
News
August 29, 2021
Israel’s BrainWatch Tech is working on prototype of device that will automatically measure and record pupillary reactions to light in patients with severe brain injury
News
June 06, 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
News
June 02, 2021
היסטוריה בהדסה: מנהל אגף נשים ויולדות בבית החולים זכה בפרס היוקרתי בעולם בתחומו
News
April 06, 2021
Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy
News
February 10, 2021
פיתוח חדש יאפשר לראשונה מעקב בזמן אמת במהלך ניתוחי מוח מורכבים
News
November 01, 2020
ניסוי ניוד תאי הגזע של ביוליין הצליח – והמניה נוסקת
News
February 26, 2020
Cancer treatment co Kahr Medical raises $18m
News
October 29, 2019
Wohl Institute for Translational Medicine Inaugurated at Hadassah Medical Organization in Jerusalem
News
October 01, 2019
הדסה וחברת י.ב.מ מקימים אקסלרטור בריאות דיגיטלית
News
October 01, 2019
Hadassah Accelerator
News
August 11, 2019
Startup Nobio gets FDA nod for antibacterial dental fillings
News
July 21, 2019
ENLIVEX ANNOUNCES DUAL LISTING ON THE TEL-AVIV STOCK EXCHANGE
News
June 05, 2019
These Israeli companies are trying to solve tough medical issues
News
May 27, 2019
שילוב מחקר מוביל, תשתיות וידע במרפאות ובמעבדות בית החולים הדסה
News
March 11, 2019
הסטארט-אפ של קבוצת הקנאביס שמשחזר רקמות הרוסות
News
July 31, 2018
Antiseptic Materials Startup Nobio Raises $3.6 Million
News
July 12, 2018
Hadassah doctors team up with Azrieli college engineers to co-develop medical devices
News
May 27, 2018
Recipharm and Hadasit partner to deliver seamless and clinical services
News
March 21, 2018
BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial
News
March 21, 2018
Immuron Reports Positive Results in NASH Clinical Trial
News
September 27, 2017
Immuron Highlights Recent Milestones in Quest to Effectively Treat Multiple Forms of Fatty Liver Diseases That Impact Millions
News
September 27, 2017
Israeli immunotherapy co Enlivex Therapeutics raising $10m
News
September 19, 2017
Enlivex Therapeutics Announces Closing Of USD 8 Million Series B Round Led by Korea Investment Partners (KIP) & Hadasit Bio Holdingings Ltd. (HBL)
News
August 27, 2017
Fidmi Medical Raises US$2 Million from B. Braun Melsungen AG
News
August 02, 2017
Hadasit Bio-Holdings (HBL) and BioTime Complete Shares Swap Transaction in Cellcure Neurosciences
Event
April 24, 2023
Hadassah BioMed Innovation Day : 30th of May 2023
Event
September 21, 2022
Hadasit conference: “Money talks! Early stage funding in the biomed sector: Pahama Hall, Hadasssah Ein Kerem, Jerusalem
Event
July 16, 2022
Hadassah Accelerator’s Class #3 is open for applications : BioHouse, Hadassah Ein Karem, Jerusalem
Event
April 05, 2022
Hadasit spring seminar “Algorithms and AI Tools as Commercial Assets in the Biomedical Domain”: Biohouse, Hadassah Ein kerem
Event
December 24, 2021
Hadasit Webinar: Health Tech Wish List – Data, Needs & Funding: Zoom Meeting
Event
December 21, 2021
Hadasit conference: “Exploring the Challenges of Preclinical Studies. Academic/Clinical/Industry collaborations” : Hadassah Ein Kerem, Pahama Hall
Event
September 15, 2020
Hadasit AI Webinar – Innovators in digital health – time for some hard learned lessons!
Event
June 29, 2020
Hadassah Accelerator Demo Day Class 2 : Zoom Meeting
Event
October 24, 2019
Opening ceremony of the new Wohl Institute For Transnational Medicine : Panama Hall, Hadassah Ein Kerem, Jerusalem
Event
October 15, 2018
From Molecule to Drug : Biohouse (Ein Carem Campus)
Event
May 30, 2018
From B2B: From Bench to Billions : Tourism Auditorium Hadassah Ein-Karem
Article
March 04, 2023
Hadassah scientists derived male and female cells from same person for the first time in the world
Article
July 22, 2022
Groundbreaking discovery at Hadassah may change the practice of treating pregnant women, fetuses, and newborns with CMV
Article
February 28, 2022
The Journey from Bench to Market: Human Embryonic Stem Cells at Hadassah
Article
January 12, 2022
Behind the scenes of Hadassah and PathKeeper collaboration on Spinal Surgery Navigation system
Article
August 11, 2021
Imaging services for preclinical studies at the WOHL Institute
View all